Prospects for the use of the method of intravesical hyperthermic chemotherapy in the treatment of patients with non-muscle invasive bladder cancer

The aim: to compare disease-free survival time (DFS) in high-risk non-muscle-invasive bladder cancer patients treated with adjuvant hyperthermic intravesical chemotherapy and standard BCG therapy. Materials and methods: patients were divided into 2 groups. Group 1 (control) included patients who...

Full description

Bibliographic Details
Main Author: Roman Chystiakov
Format: Article
Language:English
Published: PC Technology Center 2021-04-01
Series:ScienceRise: Medical Science
Subjects:
Online Access:http://journals.uran.ua/sr_med/article/view/228185